Cullinan Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,321	611	709	436	483	674
Market Cap Growth	191.83%	-13.79%	62.69%	-9.73%	-28.36%	-
Enterprise Value	988	280	134	-25	-88	355
Last Close Price	20.59	10.35	12.18	10.19	10.55	15.43
PE Ratio	-	-	-	-	4.34	-
Forward PE	-	6.70	6.70	6.70	6.70	-
PS Ratio	-	-	-	-	-	35.58
PB Ratio	4.12	1.50	1.20	0.96	0.90	1.59
P/TBV Ratio	4.15	1.50	1.20	0.96	0.90	1.59
EV/Sales Ratio	-	-	-	-	-	18.75
Debt / Equity Ratio	0.01	0.01	0.00	0.01	0.01	-
Net Debt / Equity Ratio	-1.03	-0.92	-0.67	-1.02	-0.86	-0.68
Net Debt / EBITDA Ratio	1.50	1.56	2.02	2.44	3.50	4.28
Net Debt / FCF Ratio	2.09	2.13	2.73	3.45	3.62	6.69
Asset Turnover	-	-	-	-	-	0.06
Quick Ratio	8.29	10.09	13.12	16.60	20.77	24.73
Current Ratio	8.42	10.25	13.53	17.07	21.09	25.25
Return on Equity (ROE)	-50.30%	-44.02%	-32.10%	-31.37%	22.74%	-21.57%
Return on Assets (ROA)	-31.36%	-28.23%	-22.26%	-22.80%	-16.55%	-13.03%
Return on Invested Capital (ROIC)	-7446.87%	-212.89%	-214.14%	-601.95%	-91.76%	-108.71%
Return on Capital Employed (ROCE)	-68.60%	-58.80%	-33.30%	-41.80%	-24.50%	-16.00%
Earnings Yield	-15.60%	-35.96%	-23.60%	-35.13%	23.03%	-9.73%
FCF Yield	-11.93%	-28.75%	-20.49%	-30.85%	-26.46%	-6.44%
Buyback Yield / Dilution	-2.25%	-9.82%	-29.41%	10.91%	-8.27%	-116.61%

SEC Filings: 10-K · 10-Q